1. Home
  2. Animal Drug Index - T
  3. Tylosin

Animal NDC 86098-0002-1 Tylosin

Animal Product Information

Field Name Field Value
Animal NDC Code 86098-0002-1
Proprietary Name Tylosin What is the Proprietary Name?
The proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
Non-Proprietary Name Tylosin What is the Non-Proprietary Name?
The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
Labeler Name Qilu Pharmaceutical (inner Mongolia) Co., Ltd.
Product Type Bulk Ingredient - Animal Drug
Active Ingredient(s)
  • Tylosin
Marketing Category BULK INGREDIENT What is the Marketing Category?
Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Tylosin Images

Tylosin Animal Product Labeling Information

The product labeling information includes all published material associated to a drug. Product labeling documents include information like generic names, active ingredients, ingredient strength dosage, routes of administration, appearance, usage, warnings, inactive ingredients, etc.

Table of Contents



Package Label.Principal Display Panel



Tylosin
QILU PHARMACEUTICAL (INNER MONGOLIA) CO.,LTD.
ADD:No.2 Wei Si Road, Jinchuannan District, Economy &Technology Development Zone, Hohhot City, China
Batch No.:
Mfg.Date:
Exp.Date: 4 Years
N.W.:  KG/Unit
Packaging and storage: Preserve in well-closed containers, protected from moisture.
Postcode:010080
Tel:+86-471-3260004
Fax:+86-471-3260005
Website: www.qlnm-pharma.com


* The information on this page is for an ANIMAL PRODUCT, please review the complete disclaimer below.